Ebolavirus Δ-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8502-8513

  Radoshitzky, Sheli R ^a,b   Warfield, Kelly L ^a,c   Chi, Xiaoli ^a   Dong, Lian ^a   Kota, Krishna ^a   Bradfute, Steven B ^a   Gearhart, Jacqueline D ^a   Retterer, Cary ^a   Kranzusch, Philip J ^b   Misasi, John N ^d   Hogenbirk, Marc A ^b,e   Wahl Jensen, Victoria ^f   Volchkov, Viktor E ^g   Cunningham, James M ^d   Jahrling, Peter B ^f   Aman, M Javad ^a,c   Bavari, Sina ^a   Farzan, Michael ^b   Kuhn, Jens H ^b,f,h  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Integrated BioTherapeutics Inc   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e University of Utrecht   (Netherlands)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g UNIVERSITÉ LYON 1   (France)

^h FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; FC RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN 1 2; HYBRID PROTEIN; INTEGRIN; SMALL SOLUBLE GLYCOPROTEIN; SMALL SOLUBLE GLYCOPROTEIN FC RECEPTOR FUSION PROTEIN; SOLUBLE GLYCOPROTEIN; SOLUBLE GLYCOPROTEIN FC RECEPTOR FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS SPIKE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BUNDIBUGYO VIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EBOLA VIRUS; FILOVIRUS INFECTION; HUMAN; HUMAN CELL; MARBURG VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR BINDING; RESTON VIRUS; SEQUENCE HOMOLOGY; SUDAN VIRUS; TAI FOREST VIRUS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; CELL LINE; EBOLAVIRUS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; MARBURGVIRUS; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS;

EID: 80052294344     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02600-10     Document Type: Article

References (60)

1. Aiken, C., J. Konner, N. R. Landau, M. E. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
2. Barrette, R. W., et al. 2009. Discovery of swine as a host for the Reston ebolavirus. Science 325:204-206.
3. Barrientos, L. G., A. M. Martin, P. E. Rollin, and A. Sanchez. 2004. Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP. Biochem. Biophys. Res. Commun. 323:696-702.
4. Casari, G., C. Sander, and A. Valencia. 1995. A method to predict functional residues in proteins. Nat. Struct. Biol. 2:171-178.
5. Chan, S. Y., R. F. Speck, M. C. Ma, and M. A. Goldsmith. 2000. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74:4933-4937.
6. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
7. Dalgleish, A. G., et al. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
8. 1,2): sequence and residues critical for host cell binding. J. Virol. 83:2883-2891.
9. Dyson, H. J., and P. E. Wright. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6:197-208.
10. el Mekki, A. A., and G. van der Groen. 1981. A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures. J. Virol. Methods 3:61-69.
11. Falzarano, D., et al. 2006. Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus. ChemBioChem 7:1605-1611.
12. Feldmann, H., V. E. Volchkov, V. A. Volchkova, U. Ströher, and H.-D. Klenk. 2001. Biosynthesis and role of filoviral glycoproteins. J. Gen. Virol. 82:2839-2848.
13. Gallaher, W. R. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477-478.
14. Geisbert, T. W., and P. B. Jahrling. 1995. Differentiation of filoviruses by electron microscopy. Virus Res. 39:129-150.
15. Huang, I. C., et al. 2008. Influenza A virus neuraminidase limits viral superinfection. J. Virol. 82:4834-4843.
16. Ito, H., S. Watanabe, A. Takada, and Y. Kawaoka. 2001. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75:1576-1580.
17. Ito, H. S., S. Watanabe, A. Sanchez, M. A. Whitt, and Y. Kawaoka. 1999. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J. Virol. 73:8907-8912.
18. Klatzmann, D., et al. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
19. Kuhn, J. H. 2008. Filoviruses-a compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch. Virol. Suppl. 20:13-360.
20. Kuhn, J. H., et al. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 155:2083-2103.
21. Kuhn, J. H., et al. 2006. Conserved receptor-binding domains of Lake Victoria Marburg virus and Zaire Ebola virus bind a common receptor. J. Biol. Chem. 281:15951-15958.
22. Lama, J., A. Mangasarian, and D. Trono. 1999. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 17:622-631.
23. Lee, J. E., et al. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182.
24. Leroy, E. M., et al. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575-576.
25. Li, W., et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
26. Livingstone, C. D., and G. J. Barton. 1993. Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput. Appl. Biosci. 9:745-756.
27. Mangasarian, A., et al. 1997. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6:67-77.
28. Manicassamy, B., and L. Rong. 2009. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virol. J. 6:75.
29. Manicassamy, B., et al. 2007. Characterization of Marburg virus glycoprotein in viral entry. Virology 358:79-88.
30. Mar'ânkova, R. F., S. E. Glušakova, E. V. Ryžik, and I. S. Lukaševič. 1993. Marburg virus penetration into eukaryotic cells. Vopr. Virusol. 38:74-76.
31. Maruyama, T., et al. 1999. Recombinant human monoclonal antibodies to Ebola virus. J. Infect. Dis. 179(Suppl. 1):S235-S239.
32. Maruyama, T., et al. 1999. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J. Virol. 73:6024-6030.
33. Mehedi, M., et al. 2011. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85:5406-5414.
34. Morikawa, S., M. Saijo, and I. Kurane. 2007. Current knowledge on lower virulence of Reston Ebola virus. Comp. Immunol. Microbiol. Infect. Dis. 30:391-398.
35. Radoshitzky, S. R., et al. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
36. Rancurel, C., M. Khosravi, K. A. Dunker, P. R. Romero, and D. Karlin. 2009. Overlapping genes produce proteins with unusual sequence properties and offer insight into de novo protein creation. J. Virol. 83:10719-10736.
37. Ruiz-Argüello, M. B., F. M. Goñi, F. B. Pereira, and J. L. Nieva. 1998. Phosphatidylinositol-dependent membrane fusion Induced by a putative fusogenic sequence of Ebola virus. J. Virol. 72:1775-1781.
38. Sanchez, A. 2007. Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J. Infect. Dis. 196(Suppl. 2):S251-S258.
39. Sanchez, A., M. P. Kiley, B. P. Holloway, and D. D. Auperin. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:215-240.
40. Sanchez, A., S. G. Trappier, B. W. J. Mahy, C. J. Peters, and S. T. Nichol. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U. S. A. 93:3602-3607.
41. Schornberg, K., et al. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178.
42. 1-Integrin controls ebolavirus entry by regulating endosomal cathepsins. Proc. Natl. Acad. Sci. U. S. A. 106:8003- 8008.
43. Takada, A., et al. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94:14764-14769.
44. Tompa, P., and M. Fuxreiter. 2008. Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem. Sci. 33:2-8.
45. Towner, J. S., et al. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5:e1000536.
46. Towner, J. S., et al. 2008. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 4:e1000212.
47. van der Groen, G. 1978. Growth of Lassa and Ebola viruses in different cell lines, p. 255-260. In S. R. Pattyn (ed.), Ebola virus haemorrhagic fever. Elsevier/North-Holland Biomedical Press, Amsterdam, The Netherlands.
48. Volchkov, V. E., et al. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerase. Virology 214:421-430.
49. Volchkov, V. E., H. Feldmann, V. E. Volchkova, and H.-D. Klenk. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U. S. A. 95:5762-5767.
50. Volchkov, V. E., V. A. Volchkova, O. Dolnik, H. Feldmann, and H.-D. Klenk. 2005. Polymorphism of filovirus glycoproteins, p. 359-381. In P. Roy (ed.), Virus structure and assembly. Elsevier/Academic Press, San Diego, CA.
51. Volchkov, V. E., et al. 2000. Proteolytic processing of Marburg virus glycoprotein. Virology 268:1-6.
52. Volchkova, V. A., O. Dolnik, M. J. Martinez, O. Reynard, and V. E. Volchkov. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J. Infect. Dis., in press.
53. Volchkova, V. A., H. Feldmann, H.-D. Klenk, and V. E. Volchkov. 1998. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-oriented homodimer. Virology 250:408-414.
54. Volchkova, V. A., H.-D. Klenk, and V. E. Volchkov. 1999. Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology 265:164-171.
55. Wagner, R., M. Matrosovich, and H.-D. Klenk. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12:159-166.
56. Wahl-Jensen, V., et al. 2005. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J. Virol. 79:10442-10450.
57. Watanabe, S., et al. 2000. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74:10194-10201.
58. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gpl60-CD4 complexes. J. Virol. 66:226-234.
59. Wong, S. K., W. Li, M. J. Moore, H. Choe, and M. Farzan. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279:3197-3201.
60. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.